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Objectives. This study was undertaken to evaluate the ability of
electron beam computed tomography (EBCT) to distinguish isch-
emic from nonischemic causes of cardiomyopathy by evaluating
heart failure patients for coronary calcification (CC).
Background. The etiology of heart failure, whether coronary-
induced or nonischemic, may be difficult to discern clinically.
Differentiation of ischemic from nonischemic etiology is clinically
important for both therapeutic and prognostic implications. With
its ability to noninvasively discern and quantitate coronary artery
calcification, EBCT correlates well with angiographic stenosis and
thus may be useful in distinguishing ischemic and nonischemic
cardiomyopathies.
Methods. One hundred and twenty-five patients with cardiomy-
opathy (ejection fraction <0.40) and known coronary anatomy
underwent EBCT coronary scanning to evaluate for CCs within 3
months of coronary angiography.
Results. Of the 72 patients who were found to have ischemic
cardiomyopathy, 71 patients had CC by EBCT (sensitivity 99%,
p < 0.001), mean score 798 6 899. In comparison, among the 53
patients without significant coronary artery disease (CAD) (non-
ischemic cardiomyopathy), the mean score was significantly lower
(17 6 51; p < 0.0001), and 44 patients had a CC score of 0 (no CC
present). The specificity of EBCT to exclude CAD in patients with
cardiomyopathy was 83%, using a threshold CC score of 0, and
92% for scores <80 (p < 0.001). Overall accuracy for determining
the etiology of cardiomyopathy (differentiating ischemic from
nonischemic) was 92% for this technique.
Conclusions. This prospective, blinded study indicates that
EBCT detected CC accurately and can noninvasively distinguish
between cardiomyopathy because of CAD and nonischemic causes
of left ventricular dysfunction.
(J Am Coll Cardiol 1998;32:1173–8)
©1998 by the American College of Cardiology
The etiology of heart failure, whether coronary-induced or
nonischemic, may be difficult to discern clinically. Patients with
dilated cardiomyopathy (DC) may have chest pain or electro-
cardiographic changes suggestive of coronary artery disease
(CAD), and patients with CAD-induced congestive heart
failure may present without angina or evidence of ischemia or
infarction (1–4). Differentiation of ischemic from nonischemic
etiology has both therapeutic and prognostic implications
(5,6). Because ischemic cardiomyopathy (IC) has the potential
for revascularization and thus improvement of the heart
failure, the etiology of the heart failure is often sought.
Clinicians have sought a noninvasive method to discern
those patients who are more likely to have obstructive CAD.
Regional wall motion abnormalities, as seen by radionuclide
angiography or two-dimensional echocardiography, were
thought to be specific to coronary-induced areas of myocardial
infarction (7). However, these regional abnormalities have
been recognized as occurring in patients with nonischemic
cardiomyopathy as well (8,9). Two-dimensional echocardiog-
raphy, in combination with Doppler and color flow imaging,
although commonly used by clinicians, has failed in some
studies to differentiate patients with DC from those with IC
(10,11). Studies report that up to two-thirds of patients with
nonischemic cardiomyopathy have regional wall motion abnor-
malities at rest (9,12). Because of limitations of the noninvasive
tests, coronary angiography, with increased risk in these pa-
tients, is frequently undertaken (13,14).
In 1959, Blankenhorn and Stern (15) reported an associa-
tion between coronary calcification (CC) and coronary athero-
sclerosis at autopsy (15). Since that time, multiple histology
studies have demonstrated a strong correlation between the
presence of coronary calcium and obstructive CAD (16–19).
Electron beam computed tomography (EBCT), by acquiring
x-ray images of the coronary arteries, detects the presence of
coronary calcium, which is invariably an indicator of intimal
atherosclerosis (20). With its ability to noninvasively discern
and quantitate coronary artery calcification, EBCT correlates
well with angiographic stenosis (21), and has been used to
diagnose patients with obstructive CAD with high sensitivities
(Fig. 1) (22,23). We thus examined 125 patients referred to the
cardiac catheterization laboratory with congestive heart failure
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to evaluate the ability of EBCT to distinguish ischemic from
nonischemic causes of cardiomyopathy.
Methods
Patient population. The study group consisted of 125 pa-
tients with cardiomyopathy and known coronary anatomy who
underwent EBCT scanning to assess this technique. Inclusion
criteria were: 1) a ventricular ejection fraction ,0.40; 2) under-
went coronary catheterization for evaluation of the etiology of
heart failure; and 3) underwent EBCT coronary scanning to
evaluate for the presence and amount of CC within 3 months of
angiography. All patients were New York Heart Association
functional class II to IV at the time of angiography. Patients
whose EBCT scans were performed more than 3 months before
or after the coronary angiogram were excluded from the study.
All subjects signed a written consent form approved by the
Institutional Review Board at Harbor-UCLA Medical Center.
Electron beam computed tomography. The EBCT studies
were performed with an Imatron (South San Francisco, Cali-
fornia) C-150 XL ultrafast computed tomographic scanner in
the high-resolution volume mode using a 100-ms exposure
time. Electrocardiographic triggering was used so that each
image was obtained at the same point in diastole, correspond-
ing to 80% of the RR interval for standardized calcium scoring
(21). Coronary artery visualization was obtained without con-
trast medium injection, and 30 consecutive images were ob-
tained at 3-mm intervals beginning 1 cm below the carina and
progressing caudally to include the proximal and midcoronary
arteries. Total radiation exposure using this technique was ,1
rad per patient.
A CT threshold of 2 pixels and 130 Hounsfield units (Hu)
was utilized for identification of a calcific lesion. Each focus
exceeding the minimum criteria was scored using the algorithm
developed by Agatston et al. (24), calculated by multiplying the
lesion area by a density factor derived from the maximal
Hounsfield unit within this area. The density factor was
assigned in the following manner: 1 for lesions whose maximal
density were 130 to 199 Hu, 2 for lesions 200 to 299 Hu, 3 for
lesions 300 to 399 Hu and 4 for lesions .400 Hu. A total
calcium score was determined by summing individual lesion
scores from each of four anatomic sites (left main, left anterior
descending, circumflex and right coronary arteries). The EBCT
scoring was performed by a cardiologist blinded to the clinical,
electrocardiographic and angiographic information.
Angiographic protocol. All patients underwent coronary
angiography. Patients were referred for coronary angiography
based upon the primary physicians’ concern for ischemia.
Positive noninvasive stress testing, abnormal echocardiograms
and clinical history were all used for referring patients for
cardiac catheterization. The coronary angiograms were ana-
lyzed by an experienced reader blinded to the results of the
EBCT coronary scan. Each epicardial coronary vessel (left
main, left anterior descending, circumflex and right coronary
artery) was assessed, and the visual estimation of the percent
luminal reduction for each lesion was reported. Multiple
projections were acquired to discern the maximal coronary
artery luminal narrowing. The reader recorded the maximum
stenosis in each vessel. Angiographic abnormalities were con-
Abbreviations and Acronyms
CAD 5 coronary artery disease
CC 5 coronary calcification
DC 5 dilated cardiomyopathy
EBCT 5 electron beam computed tomography
Hu 5 Hounsfield unit
IC 5 ischemic cardiomyopathy
LBBB 5 left bundle branch block
Figure 1. Electron beam CT coronary scan of a
48-year-old man with IC with three-vessel obstruc-
tive CAD on catheterization. Extensive calcifica-
tions of the left main, left anterior descending
(LAD) and circumflex artery are seen. The total
score of this patient was 1,295.
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sidered significant if $50% luminal diameter stenosis was
found in any vessel.
Classification of cardiomyopathy. Classification of the eti-
ology of left ventricular dysfunction was based entirely on
arteriographic findings. Patients were considered to have a
cardiomyopathy secondary to CAD if a significant stenosis
($50% luminal artery stenosis) was present in one or more
major coronary arteries with a wall motion abnormality in the
dependent myocardial territory. Conversely, patients were
considered to have DC if coronary angiography failed to reveal
significant CAD.
Statistical analysis. All values are reported as mean 6 SD.
Data were analyzed using chi-square and Fisher exact test for
comparing categorical variables. All tests of significance were
two-tailed, and significance was defined at the 0.05 level or
below.
Results
Patients had a mean age of 55 years (range 23 to 74) and all
had history of congestive heart failure class II to IV prior to
angiography. By coronary angiographic criteria, 72 patients
had IC and 53 had DC. Of the patients with IC, 12 had
single-vessel disease, 25 had double-vessel disease and 35 had
triple-vessel disease. In 62 patients, CAD involved the left
anterior descending artery, the left circumflex artery in 54
patients and the right coronary artery in 51 patients; 3 patients
had significant disease of the left main coronary artery.
Fifty-three patients had no obstructive CAD on angiogra-
phy and were classified as DC. The etiology of the heart failure
in the patients without obstructive coronary artery disease was
as follows: 30 had idiopathic DC, 7 had alcoholic cardiomyop-
athy, 6 had significant valvular disease, 6 had hypertensive
cardiomyopathy and 4 had congenital heart disease (atrial or
ventricular septal defects). The prevalence of hypertension was
68% in those persons with documented obstructive CAD on
angiography (ischemic group). There was no congenital heart
disease or significant valvular disease in the ischemic group.
Mean age of the patients with DC was 51 6 12 years versus
58 6 10 years in patients with CAD (p 5 0.004). The mean left
ventricular ejection fraction averaged 31 6 9 in patients with
DC and 33 6 8 in patients with CAD (p 5 NS). Clinical
variables are outlined in Table 1.
EBCT results. Significant CAD (.50% obstruction in $1
coronary artery) was found in 72 patients. Of these 72 patients
with IC, 71 patients had CC by EBCT (sensitivity 99%, p ,
0.001), mean score 798 6 899 (see Fig. 1). Of the 53 patients
without significant CAD, 44 had a CC score of zero. The mean
score for patients without significant CAD (nonischemic car-
diomyopathy) was 17 6 51, significantly less than patients with
cardiomyopathy because of CAD (p , 0.0001). The specificity
of EBCT to exclude CAD in patients with cardiomyopathy was
83% using a threshold CC score of 0 and 92% for scores ,80
(p , 0.001). A receiver operating characteristic curve was
created to determine the predictive power of the EBCT score
for obstructive CAD as a function of the minimum score
required to define a positive study. Table 2 displays the




(n 5 72) p Value
Age (yrs) 51 6 12 58 6 10 0.005
LVEF (%) 31 6 9 33 6 8 NS
Men/women 29/24 52/20 0.04
Median Score
Men 476 0 NS (men vs. women)
Women 510 0
Percent with CC
Men 83% 98% NS (men vs. women)
Women 83% 100%
Coronary score (Agatston method) 17 6 51 797 6 899 ,0.0001
Values are mean 6 SD. CC 5 coronary calcification; LVEF 5 left ventricular ejection fraction by angiographic
ventriculography; NS 5 not significant.
Table 2. Cut Points for Electron Beam Computed Tomographic Coronary Calcium Scores for













.0 99 83 89 98 92
$50 92 91 93 89 91
$80 90 92 94 88 91
.220 72 100 100 73 84
CC 5 coronary calcification; EBCT 5 electron beam computed tomography.
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sensitivity, specificity and accuracy for a variety of cutpoints for
EBCT score.
Overall accuracy for determining the etiology of cardiomy-
opathy (differentiating ischemic from nonischemic) was 92%
for this technique. There were no significant differences among
median values, prevalence of calcification, sensitivities or spec-
ificities in men and women in this study. Positive predictive
value was 89% and negative predictive value (for a negative
test having no obstructive CAD) was 98% in this population.
The mean calcium scores (6SD) for each level of angiographic
stenosis are outlined in Figure 2.
In addition to higher EBCT scores, the number of calcified
vessels also predicted with higher specificities those patients
with heart failure of ischemic etiology. Patients with calcium
present in two or more coronary arteries (counting left main,
anterior descending, circumflex and right coronary as separate
arteries) had an overall specificity of 87%, with a sensitivity of
92%. No patients with DC had calcification in all four coronary
vessels (100% specific for IC in this study).
Discussion
The incidence and prevalence of cardiomyopathy appear to
be increasing (25). The CASS study (26) and PRAISE trial
(27) have demonstrated that the treatment benefit may vary
with the etiology of the heart failure. Various noninvasive
imaging modalities have been investigated in an effort to find
an accurate and cost-effective method for distinguishing IC
from nonischemic DC. This is of paramount importance in
persons presenting with heart failure, as revascularization is
one of the few interventions demonstrated to significantly
reduce mortality. Left ventricular dysfunction secondary to
CAD needs to be identified with high sensitivity so revascular-
ization can be considered in these patients. One traditional
approach to screening patients at risk for coronary events is the
use of exercise testing. However, cardiomyopathy patients
often have reduced exercise capacity (28) and abnormal elec-
trocardiograms (29), requiring a more expensive imaging mo-
dality. Up to 60% of patients with severe cardiomyopathy have
left bundle branch block (LBBB) (11), which can mask the
evidence of previous infarction and make the interpretation of
electrocardiographic changes with exercise testing (without
imaging) impossible (10). Noninvasive imaging exercise tech-
niques such as thallium-201 myocardial scintigraphy and exer-
cise echocardiography have been used to try to distinguish IC
from DC with variable success; however, reduced exercise
capacity (28), reduced coronary flow reserve (30,31) and LBBB
(29) have all led to increased false positive results and reduced
specificity for both nuclear and echocardiographic stress tests.
These tests have further reduced specificity and predictive
values with increasing left ventricular dysfunction (32,33).
Dobutamine (34) stress tests have been used; however, there is
an increased incidence of ventricular arrhythmias (12) and
these tests are less diagnostic in cases with LBBB (29).
Dipyridamole-thallium-201 (28,35) and positron emission to-
mography (36) both have less side effects and accuracy up to
90% in differentiating cardiomyopathies; however, both re-
quire intravenous injections and are both time consuming and
quite costly, especially compared to EBCT ($375 to $400 per
study, total patient time less than 5 min).
Electron beam computed tomography, with its ability to
distinguish and quantify calcium in the coronary arteries, has
been used to diagnose those patients with obstructive CAD
with high sensitivities. Electron beam CT is an imaging tech-
nique that allows rapid, accurate, noninvasive identification
and quantification of coronary artery calcium, a marker of
atherosclerosis. Electron beam CT-detected CC has been
compared to angiography and demonstrated sensitivities for
obstructive CAD ranging from 88 to 100% (18–21). With high
sensitivities for disease, a negative test has a low probability of
being associated with obstructive CAD, with negative predic-
tive values approaching 100% in many studies. This rapid
image acquisition avoids the artifacts resulting from the mo-
tion of the heart and allows very small calcium deposits on the
epicardial coronary arteries to be seen. The presence of
calcium in the coronary arteries, especially in multiple arteries
Figure 2. Mean EBCT scores for pa-
tients with differing disease states as
defined by angiography. Those pa-
tients with non-ischemic cardiomyop-
athy (no CAD or ,50% by angiogra-
phy) had the lowest EBCT calcium
scores. The EBCT scores generally
track with the amount of angio-
graphic disease, with the highest
scores in those patients with three-
vessel disease by angiography.
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or in large quantity, implies an ischemic etiology to the
cardiomyopathy with high accuracy in this study. Although a
significant portion of the population will have some coronary
calcium, the quantification can help further distinguish the two
similar clinical entities. Utilization of a lower EBCT score (i.e.,
zero) would impart a higher sensitivity and negative predictive
value for CAD, thus allowing the vast majority of patients with
significant disease to undergo revascularization. The power of
a negative test would be maximized, and receiver operating
characteristic curve analysis demonstrates the highest area
under the curve for scores .0. Higher specificities can be
obtained with higher EBCT score cut points (Table 2). The
other intrinsic advantages of EBCT coronary scanning is that
there is no need for exercise or intravenous catheters, it is not
dependent upon concurrent medications or electrocardio-
graphic findings and has no reported adverse side effects.
Study limitations. This is a single-center experience involv-
ing patients referred for angiography for evaluation of heart
failure. Differentiation of ischemic from nonischemic DC
solely on the basis of angiographic criteria is not entirely
precise. Cardiomyopathy of unknown cause may coexist with
CAD, so that the CAD may not be the cause of ventricular
dysfunction (37). Conversely, myocardial infarctions can occur
at a site with nonobstructive CAD (at locations with ,50%
stenosis by angiography) (38), or secondary to spasm, cocaine,
emboli, etc. Many of the ischemic patients had hypertension, a
potential cause of nonischemic cardiomyopathy. The three
patients in this study that had nonobstructive CAD on angiog-
raphy were classified as DC (because of angiographic criteria
for etiology); however, autopsy study of patients can confirm
the exact etiology of cardiomyopathy. In this study, all three
patients with nonobstructive CAD had coronary calcium by
EBCT. Although the “true” etiology of heart failure might
never be known, EBCT allows for precise identification of
those patients with obstruction on angiography who potentially
might benefit from revascularization.
Conclusions. Electron beam CT has achieved a substantial
degree of standardization and ease of implementation suffi-
cient to make it applicable to wide populations in the evalua-
tion of cardiomyopathies. Electron beam CT, an inexpensive
and fast technique, can potentially help obviate the need for
invasive coronary angiography in patients in whom the clinical
etiology of the cardiomyopathy is not apparent. This prospec-
tive, blinded study indicates that EBCT detected CC accu-
rately, and noninvasively distinguished between cardiomyopa-
thy because of CAD and nonischemic causes of left ventricular
dysfunction in this study. Cost-effectiveness modeling with this
modality needs to be performed before widespread use of this
clinical tool can be warranted.
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